•
Mar 31, 2013

ResMed Q3 2013 Earnings Report

Total Revenue
$384M
Previous year: $349M
+9.9%
EPS
$0.58
Previous year: $0.44
+31.8%
Gross Profit
$239M
Previous year: $210M
+13.8%
Cash and Equivalents
$1.01B
Previous year: $776M
+30.5%
Free Cash Flow
$87.1M
Previous year: $76.1M
+14.3%
Total Assets
$2.37B
Previous year: $2.13B
+11.6%

ResMed

ResMed